World news – CA – Enbridge (ENB) misses third-quarter earnings estimates, year-on-year revenue drops

Enbridge Inc announced that its earnings per share in the third quarter of 2020 were 36 cents, below the Zacks Consensus estimate of 40 cents, and earnings deteriorated from 42 cents a year earlier

The weak quarterly results were due to the decline in main system productivity, which was partially offset by contributions from the highest levels of gas transportation business

The leading North American energy infrastructure company separately announced its goal of achieving net zero greenhouse gas emissions by 2050.The company has added its interim goal to reduce greenhouse gas emissions intensity by 35% by 2030

>

In the third quarter of 2020, the company reported to DCF $ 2,088 million CAD, which is down from CAD $ 2,105 million a year ago.

Enbridge operates its business through five sectors – fluid pipelines, gas transmission and distribution, gas distribution and storage, renewable energy generation, and energy services

Fluid Pipelines: Sector Adjusted Earnings Before Interest, Income, Depreciation and Amortization (EBITDA) 1C $ 732 million, down from C $ 1,826 million in the previous quarter of the year, lower contributions from the Gulf Coast, Mid-Continent System, Main System, and Regional Oil Sands System primarily led to poor performance.

Gas Transportation and Intermediation: Total adjusted profits for the sector were C $ 945 million, up slightly from C $ 944 million in the third quarter of 2019 Higher contributions from US gas transportation business led to an uptick

Gas Distribution and Storage: The unit generated a profit of $ 315 million CAD, compared to $ 255 million in the previous quarter. The increase in distribution fees and growth in the customer portfolio led primarily to outperformance

Renewable Energy Generation: The sector reported C $ 93 million in profits, up from C $ 82 million in the previous quarter, thanks to contributions from the Hohe See Offshore Wind Power Project

Energy Services: The sector incurred a loss of 110 million Canadian dollars compared to a profit of 27 million Canadian dollars in the third quarter of 2019

At the end of the third quarter of 2020, the company reported a total debt of 67132 million Canadian dollars, cash and cash equivalents, and 657 million Canadian dollars debt to capitalization ratio was approximately 051

For 2020, the company reaffirmed its guidance on discounted cash flows per share in the range of 4 Canadian dollars 50 to 4 Canadian dollars 80 Bridge is optimistic that there will be a gradual recovery in energy demand during the remainder of this year and the whole of 2021

p>

The company is currently ranked # 3 (Hold) Zacks. Meanwhile, there are a few top-rated players in the energy field such as Sunoco LP SUN, Matador Resources Company MTDR and Antero Resources Corporation AR while Sunoco ranks first in the Zacks ranking (Strong buy) Matador and Antero rank Zacks at # 2 (buy) You can see the full list of Zacks # 1 stocks today here

Matador has seen rampant reviews of its 2020 final earnings estimate in the past 30 days.

The biotechnology sector is expected to exceed US $ 775 billion by 2024 as scientists develop treatments for thousands of diseases. They are also finding ways to modify the human genome to erase our vulnerability to these diseases.

Zacks recently released Century of Biology: 7 Biotech Stocks to Buy Now to Help Investors Profit from 7 Stocks Preparing for Outperforming Our recent biotech recommendations achieved gains of 50%, 83% and 164% in less than two months. The performance of stocks in this report should be better.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 of the best stocks for the next 30 days. Click for this FREE Sunoco LP (SUN): Free Stock Analysis Report Enbridge Inc (ENB): Free Stock Analysis Report Matador Resources Company (MTDR): Free Stock Analysis Report Antero Resources Corporation (AR): Free Stock Analysis Report To read this article on Zacks.com click here Zacks Investment Research

Pfizer Inc (NYSE: PFE) and its partner BioTech SE (NASDAQ: BNTX) have reported an interim analysis of a Phase 3 study of a BNT 162b2 coronavirus candidate. The trial showed a 90% efficacy rate at the seven-day mark after applying a second dose of the vaccine. July 27 companies have registered 35,358 healthy volunteers in the experiment The market is generally seeing a rally in the news, as the SPDR S&P 500 Trust ETF (NYSE: SPY) rose 5% to $ 366.29 in pre-market trading Dow Jones futures are set to rise. 5%, or about 1,300 points Related link: Pfizer-BioNTech’s COVID-19 vaccine is 90% effective, and the EUA file is likely to be submitted by late November Joe Biden responded: In a statement, President-elect Joe Biden said he was informed tonight « I congratulate the brilliant women and men who helped achieve this breakthrough and gave us such hope. » While Biden remained positive, it also took the time to remind Americans to wear masks and to practice the study, he said. “The mask remains a stronger weapon against the virus than the vaccine.” Biden also said that America is losing more than 1,000 people a day due to Covid-19 and that cases are on the rise. “Today’s news is good news, but it does not change that fact,” Biden said, wearing masks. DONALD TRUMP: President Donald Trump took to Twitter to say the following:> The stock market is coming soon 90% effective report like this great news! >> – Donald J. Trump (@realDonaldTrump) November 9, 2020 Trump’s first comment on vaccine news was its effect on the stock marketTrump’s tweet broke a series of tweets from last night that published Fox News videos that Twitter described as « this allegation about election fraud is disputed. » What next: Pfizer will continue safety data in the trial The company plans to introduce the vaccine for an emergency use license Pfizer said it can produce Up to 50 million vaccines in 2020 and up to 13 billion doses in 2021 Pfizer shares rose 14% to $ 41 65 in pre-market trade BioNTech shares rose 25% to $ 114 88 in pre-market trade See more From Benzinga * Click here for option deals from Benzinga * S&P 500 rallies 1% every of the last four days, something that’s only done 3 times since WWII * How the odds are for Trump, Biden flips up on Election Night (C) 2020 Benzinga.com does not provide benzinga investment advice. All rights reserved

Former Vice President Biden has made a detailed proposal that includes tax increases for people whose taxable income exceeds $ 400,000 – mainly targeting the top 1% President Trump wants to keep the tax cuts that went into effect in 2018, which the owners have benefited from Significantly high income

Jim Cramer shared his thoughts on what a potential COVID-19 vaccine means from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) for higher-traded tech stocks such as Stay HomeStay home stocks: Kramer said S&P 500 and Dow rose by the right amount, but Nasdaq futures rose a lot and he said many companies on the Nasdaq are not benefiting from the vaccine Kramer said the upcoming vaccine is not good news for cloud stocks and not good for the big spike in stocks Some companies rose this year as a stay-at-home game: « How many Nasdaq stocks can rise on this basis? » Kramer said some stocks are rising with the election of Joe Biden and the potential positives from improved relations with China and that is goodRelated link: Biden and Trump’s Response to Pfizer Vaccine Update, Stock Market Rise: Great News! Buying Airlines: Kramer said stocks that are rising like airlines and parks are taking the right steps Kramer said he would be “more comfortable buying airline shares of 10% compared to cloud stock, down 5%.” Andrew Ross Sorkin Kramer asked whether the shares were Moving upwards worth buying because the timeline for approval of the COVID-19 vaccine has not changed Kramer said that if you wait to buy, you will miss the full move. ”Stocks are trading in anticipation,” Kramer said. Price action: SPDR S&P 500 index rose Trust ETF (ARCA: SPY) up 4% to $ 365 75 in pre-market trade Invesco QQQ ETF (NASDAQ: QQQ) rose 1% to $ 296 55 airline stocks rose higher, as Southwest Airlines Co (NYSE) shares rose 1%. Shares in American Airlines Group (NASDAQ: AAL) gained 25%, and shares of JetBlue Airways Corporation (NASDAQ: JBLU) rose 18%, while the value of the Global JETS ETF (NYSE: JETS) rose 20%, reaching To $ 21 35 on Monday Watch more Benzinga * Click here for option deals from Benzinga * Biden and Trump react to Pfizer vaccine update, stock market rallies: « Great news! » * Children push parents to buy electric cars: Study (C) 2020 Benzinga.com does not provide Benzinga investment advice All rights reserved

Quinn analyst Geoffrey Osborne released a buy valuation Monday seeing shares reach $ 22, up from Friday’s closing price of $ 10.86 and stocks rose more than 30% at midday

Pfizer’s stock erupted in early November after the pharmaceutical company’s coronavirus vaccine proved 90% effective in a final phase study, but if the pharmaceutical company’s stock is buying now?

With pension plans fading, investors today may want to look to pensions to bridge the retirement gap, one expert said.

Nio got bullish endorsement from JR Rebecca Wayne, Morgan analyst, raising its share price target based on the belief that the Shanghai-based company will be the « winner » in the electric vehicle market

Hemp stocks continued to rise after Monday’s election, with two Canadian industry leaders, Canopy Growth Corp and Aurora Cannabis Inc reporting profits amid mounting hopes for UX reform under Democratic President-elect Joe Biden

(Bloomberg) – Eric Yuan is, in many ways, the poster child for the Coronavirus economy His company Zoom Video Communications Inc. has hosted school lessons, family gatherings and business meetings for more than 300 million participants per day during the pandemic, video conferencing site inventory has risen by more than 500% this year. And, Yuan, a Chinese-born immigrant to the US, was at one point worth $ 28 6 billion – the 40 richest people on Earth This remarkable rise took a hit on Monday after Pfizer said the Covid-19 vaccine it developed with BioNTech SE had prevented more than 90%. % Of infections in one study, the most encouraging scientific progress yet in the battle against the virus, have soared airlines, oil giants and hotel operators, but stocks that have benefited from the closings and work from home, such as Peloton Interactive, Netflix Inc and the Ocado Group supermarket Plc via The internet, it’s all down, the main question now is whether these extraordinary gains can continue, or whether people will stop using the services of companies like Zoom after the pandemic is over and return to the workplace. Natural “I don’t think the trend around e-commerce, video collaboration or shifting to the cloud will change as a result of the vaccine,” said Bloomberg Intelligence analyst Mandeep Singh. Ratings seem rich for some of these names, but some are multi-year growth stories. This is just a natural flip-flop. Investors are turning to sectors that have been depressed by the pandemic such as travel, casinos and hospitality, and Zoom’s stock fell 13% at 12:30 pm in New York, wiping more than $ 4 billion of net worth in Yuan He sold more than $ 275 million in shares. Zoom this year and it’s still worth about $ 21 billion, according to the Bloomberg Billionaires Index Peloton founder John Foley has become a billionaire thanks to the staggering rise in shares of the home fitness company He’s down by more than $ 200 million after the stock fell by as much as 25% FedEx Corp. Chairman Fred Smith’s net worth fell by $ 300 million as it fell Fast shipping company shares by 6% His fortune rose more than 70% this year until Friday as telecommuting and booming e-commerce fueled demand for package delivery services Reed Hastings, chief executive of movie and TV streaming service Netflix, saw his net worth drop by more than $ 700 million Jay Chowdhury, CEO of cybersecurity company Zscaler Inc, co-founder of Ocado Tim Steiner and Forrest Li – the billionaire behind Sea Ltd, the largest internet company in Southeast Asia – has also backed off in the fallout from the study of Pfizer vaccine « Ortega, Rolling ». And billionaires keep their winnings Zara founder Amancio Ortega’s fortunes and his daughter Sandra rose through their stakes in fast-fashion retailer Inditex SA as the vaccine study boosted consumers’ hopes for Returning to the brick and mortar stores their fortunes also saw an increase in their wealth on Monday, the hotelier Robert Rolling, as well as the industrialist George Schaeffler and the Daishman family who control one of the largest shoe retailers in Europe Some companies are optimistic that even after the pandemic is brought under control, people will continue to use their services. How can anyone get tired of Zoom?  » CFO Kelly Stikelberg said in an interview with Bloomberg TV in June, « Video communication has been integrated into all aspects of our lives. More articles like this, please visit us at Bloomberg comSubscribe now to keep up with the most trusted business news source » © 2020 Bloomberg The Else

Stocks sailed to record highs on Monday morning as traders took promising data on a leading COVID-19 vaccine candidate in addition to President-elect Joe Biden’s victory in the US presidential election, which ended with long days of harassment for any candidate who would win the White House

Together with the rest of Wall Street, you will indulge in the euphoria that accompanies a bull market at the last stage. It has been more than a month since the stock market reached its all-time high, and it is possible that the last revolutionary moment has occurred. Time – and that a new bear market has already started. While this does not mean that a new bear market has started, it also does not mean that the market has not started.

Shares in AMC and other theaters rose after Pfizer and BioNTech announced positive news about the candidate vaccine

Goldman Sachs thinks receiving positive news on the COVID-19 front is essential to keeping the stock market rally after the election

Joe Biden is now the president-elect, but unlike a previous Trump statement, the coronavirus is far from yesterday’s news after a potential Democrat victory. News of the spike in Covid-19 cases may have subsided during last week’s election frenzy, but the global battle against taming The epidemic has not yet won, but how close are we to achieving the desired vaccine? The race is still the first to market a solution as many names have candidate vaccines in Advanced Studies (MRNA). Moderna remains one of the leaders, with the COVID-19 Candidate vaccine mRNA-1273, currently in Phase 3 trials, after meeting with the Head of Relationships. Investors in Moderna, Oppenheimer analyst Hartag Singh believes the company is still on track to reveal interim data in the next few weeks Singh said: “A uselessness analysis will also be done at that time, but we think the odds are slim (<5%). ) Against this negative reading, based on preclinical and clinical data published to date 'If the provisional data proves to be positive, Singh says potential emergency use licensing by the Food and Drug Administration (EUA) and prior US approvals "should happen quickly." While it is not surprising that the development of mRNA-1273 is currently taking center stage, Moderna Also progressing with other vaccination programs The company recently announced that it will start developing a vaccine against seasonal influenza. Singh says the flu vaccine space is an "interesting new business area", with global sales estimated at $ 4 billion, and Singh indicates "the true likelihood of approval of an MRNA flu vaccine." Just in time for the 2022 influenza season, ”he considers it another reason to“ stay optimistic ”in stock. The analyst concluded,“ We ​​are still a fan of the MRNA platform that is scalable and implemented across different pipeline candidates. ”“ We love the big picture of MRNA in 2021, especially as a potential company Income-generating starting in 2021 (with DTAs of $ 982 million net worth of & NOLs worth $ 471 million as of year 19) Profit can also attract the attention of another class of investors. Most importantly, mRNA-1273 approval can validate the prophylactic vaccine privilege in the form of a bullish Singh approach backed by superior performance (A Buy) rating and US $ 108 target price This figure indicates a 40% rise from current levels (to see Singh's record, Click here) Majority of street analysts support Singh's call based on 9 buys and 1 contract and sell, each with a consensus rating of Average Buy at $ 98 At 20, the average target price indicates a potential rise of approximately 27% over the following months (see Moderna Stock Analysis at TipRanks) To find good ideas for trading healthcare stocks with attractive valuations, visit Best Stocks to Buy from TipRanks, a newly launched tool that unites all the stock insights for TipRanks Disclaimer: The opinions in this article are only those of the premium analyst Content It is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

Are Boeing stocks a good buy now because coronavirus is wreaking havoc on aviation? See the fundamentals of the flying giant and the stock chart

Workhorse started its earnings from electric vehicle stocks but Workhorse stock declined as it gave weak direction to production in the fourth quarter Nicolas Deserved

Joe Biden is the President-elect now verifying the IRA’s investments and the 401 (k) that should get a boost from Biden’s win

When searching for the best AI stocks to buy, identify companies that are using AI technology to improve products or gain a strategic advantage, such as Microsoft, Netflix, and Nvidia

Will Democrats hurt the stock market? No, say professionals at Wall Street, although some investors have expressed concern about how the president-elect’s policies affect stocks, as well as the effect of a potential « blue wave », dominated by Democrats in the White House, Senate and Congress, analysts have historically said that stocks Outperforming regardless of which party controls the White House or Congress Looking at data from the past 78 years, party control had a limited impact on the broader S&P 500 Starting in 1942, the data shows that the Republican and Democratic majorities in the House and Senate had little impact On stock prices in the two-year period after the election The same is true when comparing the number of gained or lost party seats in the House and Senate with share prices for S&P 500 during that period. Similar results are seen in the period from November to November, which is a measure of market sentiment towards the elections. With all this in mind, we used a database. TipRanks As we search for compelling plays by relying on two in particular, the platform has identified two stocks that have received overwhelming bullish praise from the street, enough to win the consensus of Atlanta-based PulteGroup (PHM) PulteGroup analyst is the third largest. To build homes in the United States, where they generate about $ 10 billion in annual revenue, the economic expansion we’ve seen over the past three years has been beneficial to the company, as wage growth and expansion in the labor market put money in people’s hands. The COVID-19 pandemic struck during the first quarter of the year. Year, and PulteGroup saw a drop in profits and revenues – but the first quarter was the slowest company over the year, with net profits rising during the fourth quarter not only continuing P HM is following this pattern, but the quarterly results in 2020 consistently beat expectations and posted annual gains in the third quarter, the most recent report reported, EPS was $ 1 34, the highest in more than two years, in terms of revenue of $ 2 95 billion. The stock price, PHM fell in February / March, along with the overall markets, but the stock has been rising since then PHM hit its lowest level on March 23, and over the past seven and a half months it has rebounded 148%, writes analyst Michael Dahl, who RBC Capital’s PHM covers, “While growth at the moment is the rage, the balanced and yield-based PHM model has historically required a stronger premium, and we expect this to return in the coming months as investors shift their focus looking at more challenging companies.” And community statistic trends and inflationary pressures across the peer group most importantly, that PHM remains in a good position on the ground with more than 7 years in control (53% owned, 47% optional), which is positive in a land-limited and inflated environment; Combined with pricing strength, this should allow it to maintain GM> 24%. ”Dahl ranks the stock as an outperformer (i e buy) and its $ 53 target price points to a 22% rally for the next year (to see Dahl’s record, click here) visually. General, PulteGroup has a strong buying rating from analyst consensus, based on 6 buys and 2 contracts set in recent weeks: $ 43 a share 12 trading price and $ 55 67 average target price means a one-year upside of 225% (see PHM stock analysis At TipRanks) Dynatrace, Inc (DT) With our second inventory, we’re moving into the world of artificial intelligence. Dynatrace is an AI company that provides cloud platforms that monitor and manage business programs. The company’s AI can manipulate the infrastructure in system architecture and cloud software, making it a comprehensive network management tool. Seeking to reduce system stress The popularity of Dynatrace products only grew during the Coronavirus crisis as white-collar desks make a strong shift toward working remotely and virtual desktops, robust systems management has become a valuable commodity ever since it was reported. In mid-March, DT shares showed investors a healthy recovery. The stock has risen 90% since its lowest level in March. This stock covers Needham, Jack Andrews describes Dynatrace as the right company in the right place at the right time « [with] issuance cycles accelerate and services become hybrid , The demand for DT is increasing due to the increasing complexity of enterprise systems The DT platform provides automation / artificial intelligence to alert and dynamically monitor the structure of systems. We believe the suitability of a DT product may enable it to capture a large mix of AI-enabled enterprise workloads as it replaces the existing tool and with customers expanding into additional modules, ”Andrews said in line with his comments, Andrews appointed DT buy rating, price target of $ 50 indicates confidence in a one-year rise of 61% (to see Andrews record, click here) Overall, Wall Street liked this stock, and had a consensus rating from excellent analysts, as TipRanks’ analysis showed that DT is a strong buy out of 11 analysts tracked by TipRanks in the past three months, 10 were bullish, while only 1 remained on the sidelines with a potential return of nearly 34%, the agreed target price for the stock stands at $ 50 36 (see DT Stock Analysis At TipRanks) To find good stock trading ideas with attractive reviews, visit Best Stocks to Buy from TipRanks, a newly launched tool that unites all the stock insights for TipRanks Disclaimer: The opinions presented in this article e Only the opinions of distinguished analysts. The content is intended for informational purposes only. It is very important to do your own analysis before making any investment.

NYSE: ENB, Stock, TSX, Enbridge, Earnings, Finance